Nerve transcriptomes in autoimmune and genetic demyelinating neuropathies: Pathogenic pathway assessment of nerve demyelination

J Neuroimmunol. 2023 Nov 15:384:578220. doi: 10.1016/j.jneuroim.2023.578220. Epub 2023 Oct 13.

Abstract

The pathogenesis of autoimmune demyelinating neuropathies is poorly understood compared to inherited demyelinating forms. We performed whole transcriptome (RNA-Seq) using nerve biopsy tissues of patients with different autoimmune and inherited demyelinating neuropathies (CIDP n = 10, POEMS n = 18, DADS n = 3, CMT1 n = 3) versus healthy controls (n = 6). A limited number of differentially expressed genes compared to healthy controls were identified (POEMS = 125, DADS = 15, CMT = 14, CIDP = 5). Divergent pathogenic pathways including inflammatory, demyelinating and neurite regeneration such as with the triggering receptor expressed on myeloid cells (TREM1) part of the immunoglobulin superfamily and RhoGD1 are found. Shared and discordant pathogenic injury are discovered between autoimmune and inherited forms.

Keywords: Autoimmune; CIDP; Demyelinating; Inflammatory; POEMS; Transcriptome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carrier Proteins
  • Humans
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating* / genetics
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating* / pathology
  • Transcriptome

Substances

  • amsonic acid
  • Carrier Proteins